Review



human sat antibody  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    R&D Systems human sat antibody
    Human Sat Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 11 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human sat antibody/product/R&D Systems
    Average 94 stars, based on 11 article reviews
    human sat antibody - by Bioz Stars, 2026-03
    94/100 stars

    Images



    Similar Products

    94
    R&D Systems human sat antibody
    Human Sat Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human sat antibody/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    human sat antibody - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    90
    Cell Signaling Technology Inc antibodies against human sat1
    Antibodies Against Human Sat1, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies against human sat1/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    antibodies against human sat1 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    95
    Proteintech anti ssat protein tech 1078 1 ap human
    Anti Ssat Protein Tech 1078 1 Ap Human, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti ssat protein tech 1078 1 ap human/product/Proteintech
    Average 95 stars, based on 1 article reviews
    anti ssat protein tech 1078 1 ap human - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    93
    R&D Systems human sat1 antibody
    A Schematic mechanism of the depletion of polyamines by DENSpm, B <t>SAT1</t> protein expression, C Alterations of polyamine metabolism-related metabolites, D , E viral PA mRNA expression by treating DENSpm or synthetic polyamines, and F viral NP protein expression. DENSpm-N1 N11-diethylnorspermine, SAT1 spermidine/spermine N1, acetyltransferase, PA polymerase, NA neuraminidase.
    Human Sat1 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human sat1 antibody/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    human sat1 antibody - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    90
    Boster Bio sat1
    DSF/Cu inhibits nasopharyngeal carcinoma cells via the ferroptosis pathway. ( A ) Western blot analysis for the expression of p53-related proteins in 5-8F treated with DSF/Cu (1 μM/1 μM); the p53 inhibitor Pifithrin-α (20 μM) was pretreated for 12 h. Data are shown as means ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001, n = 3. ( B , C ) RT-qPCR analysis of Ptgs2 and <t>SAT1</t> mRNA levels in 5-8F. Data are shown as means ± SD. * p < 0.05, *** p < 0.001 vs. control group, n = 3. ( D ) The expression of SAT1 was detected by Western blotting in 5-8F, after cultured with DSF/Cu (1 μM/1 μM). Data are shown as means ± SD. *** p < 0.001, n = 3. ( E ) RT-qPCR analysis of ALOX15 mRNA levels in 5-8F. Data are shown as means ± SD. ** p < 0.01, *** p < 0.001 vs. control group, n = 3. ( F ) Lipid ROS production in 5-8F treated with DSF/Cu (1 μM/1 μM) for 6 h was assessed by flow cytometry using C11-BODIPY. NAC was pretreated for 12 h. Data are shown as means ± SD. *** p < 0.001, n = 3. ( G ) The percentage of viable 5-8F cells after being treated with DSF/Cu (1 μM/1 μM) for 24 h. Inhibitors were pretreated for 12 h. DMSO solvent was used as a control. Data are shown as means ± SD. *** p < 0.001 vs. DSF/Cu group (the second group), n = 3.
    Sat1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/sat1/product/Boster Bio
    Average 90 stars, based on 1 article reviews
    sat1 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    A Schematic mechanism of the depletion of polyamines by DENSpm, B SAT1 protein expression, C Alterations of polyamine metabolism-related metabolites, D , E viral PA mRNA expression by treating DENSpm or synthetic polyamines, and F viral NP protein expression. DENSpm-N1 N11-diethylnorspermine, SAT1 spermidine/spermine N1, acetyltransferase, PA polymerase, NA neuraminidase.

    Journal: Communications Biology

    Article Title: Nasal symbiont Staphylococcus epidermidis restricts influenza A virus replication via the creation of a polyamine-deficient cellular environment

    doi: 10.1038/s42003-024-06706-4

    Figure Lengend Snippet: A Schematic mechanism of the depletion of polyamines by DENSpm, B SAT1 protein expression, C Alterations of polyamine metabolism-related metabolites, D , E viral PA mRNA expression by treating DENSpm or synthetic polyamines, and F viral NP protein expression. DENSpm-N1 N11-diethylnorspermine, SAT1 spermidine/spermine N1, acetyltransferase, PA polymerase, NA neuraminidase.

    Article Snippet: Human ODC1 antibody (molecular weight 61 kDa, cat# MAB2695-SP, primary antibody 1:500), anti-β-actin antibody (molecular weight 43 kDa, primary antibody 1:500), and human SAT1 antibody (molecular weight 20 kDa, cat #AF-1786) were purchased from R&D Systems (Minneapolis, MN, USA).

    Techniques: Expressing

    DSF/Cu inhibits nasopharyngeal carcinoma cells via the ferroptosis pathway. ( A ) Western blot analysis for the expression of p53-related proteins in 5-8F treated with DSF/Cu (1 μM/1 μM); the p53 inhibitor Pifithrin-α (20 μM) was pretreated for 12 h. Data are shown as means ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001, n = 3. ( B , C ) RT-qPCR analysis of Ptgs2 and SAT1 mRNA levels in 5-8F. Data are shown as means ± SD. * p < 0.05, *** p < 0.001 vs. control group, n = 3. ( D ) The expression of SAT1 was detected by Western blotting in 5-8F, after cultured with DSF/Cu (1 μM/1 μM). Data are shown as means ± SD. *** p < 0.001, n = 3. ( E ) RT-qPCR analysis of ALOX15 mRNA levels in 5-8F. Data are shown as means ± SD. ** p < 0.01, *** p < 0.001 vs. control group, n = 3. ( F ) Lipid ROS production in 5-8F treated with DSF/Cu (1 μM/1 μM) for 6 h was assessed by flow cytometry using C11-BODIPY. NAC was pretreated for 12 h. Data are shown as means ± SD. *** p < 0.001, n = 3. ( G ) The percentage of viable 5-8F cells after being treated with DSF/Cu (1 μM/1 μM) for 24 h. Inhibitors were pretreated for 12 h. DMSO solvent was used as a control. Data are shown as means ± SD. *** p < 0.001 vs. DSF/Cu group (the second group), n = 3.

    Journal: Cancers

    Article Title: Disulfiram/Copper Induces Antitumor Activity against Both Nasopharyngeal Cancer Cells and Cancer-Associated Fibroblasts through ROS/MAPK and Ferroptosis Pathways

    doi: 10.3390/cancers12010138

    Figure Lengend Snippet: DSF/Cu inhibits nasopharyngeal carcinoma cells via the ferroptosis pathway. ( A ) Western blot analysis for the expression of p53-related proteins in 5-8F treated with DSF/Cu (1 μM/1 μM); the p53 inhibitor Pifithrin-α (20 μM) was pretreated for 12 h. Data are shown as means ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001, n = 3. ( B , C ) RT-qPCR analysis of Ptgs2 and SAT1 mRNA levels in 5-8F. Data are shown as means ± SD. * p < 0.05, *** p < 0.001 vs. control group, n = 3. ( D ) The expression of SAT1 was detected by Western blotting in 5-8F, after cultured with DSF/Cu (1 μM/1 μM). Data are shown as means ± SD. *** p < 0.001, n = 3. ( E ) RT-qPCR analysis of ALOX15 mRNA levels in 5-8F. Data are shown as means ± SD. ** p < 0.01, *** p < 0.001 vs. control group, n = 3. ( F ) Lipid ROS production in 5-8F treated with DSF/Cu (1 μM/1 μM) for 6 h was assessed by flow cytometry using C11-BODIPY. NAC was pretreated for 12 h. Data are shown as means ± SD. *** p < 0.001, n = 3. ( G ) The percentage of viable 5-8F cells after being treated with DSF/Cu (1 μM/1 μM) for 24 h. Inhibitors were pretreated for 12 h. DMSO solvent was used as a control. Data are shown as means ± SD. *** p < 0.001 vs. DSF/Cu group (the second group), n = 3.

    Article Snippet: Total cell proteins were separated by 10% SDS-PAGE, transferred to polyvinylidene difluoride membranes, and probed with antibodies directed against human PARP, Caspase3, Cleaved-Caspase3, p-JNK, p38, p-p38 and BAX (1:1000, Cell Signaling Technologies, CST, Boston, MA, USA), JNK (1:500, Wanleibio, Shenyang, China), p53 and p21 (1:1000, proteintech, Chicago, IL, USA), ALDH1A1 and ALDH2 (1:100, Boster, Wuhan, China), SAT1 (1:500, Elabscience, Wuhan, China), α-SMA (1:100, Boster, Wuhan, China), and FAP-α (1:400, R&D Systems, Minneapolis, MN, USA).

    Techniques: Western Blot, Expressing, Quantitative RT-PCR, Cell Culture, Flow Cytometry